Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review.

about

Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review.

Item

http://www.wikidata.org/entity/Q47838653

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Brain metastasis in non-small ...... n cases and literature review.

@en

Brain metastasis in non-small cell lung cancer

@nl

type

Item

label

Brain metastasis in non-small ...... n cases and literature review.

@en

Brain metastasis in non-small cell lung cancer

@nl

prefLabel

Brain metastasis in non-small ...... n cases and literature review.

@en

Brain metastasis in non-small cell lung cancer

@nl

P1476

Brain metastasis in non-small ...... n cases and literature review.

@en

P2093

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Ping Wang

http://www.w3.org/2001/XMLSchema#string

Puchun Er

http://www.w3.org/2001/XMLSchema#string

Qingsong Pang

http://www.w3.org/2001/XMLSchema#string

Tian Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis

Radioresistance of Brain Tumors

Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q.

The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients

Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis.

EGFR Exon 18 Mutations in East Asian Patients with Lung Adenocarcinomas: A Comprehensive Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors

The Value of the History and Physical for Patients with Newly Diagnosed Brain Metastases Considering Radiosurgery.

Prognostic factors analysis in EGFR mutation-positive non-small cell lung cancer with brain metastases treated with whole brain-radiotherapy and EGFR-tyrosine kinase inhibitors.

P304

418-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.20892/J.ISSN.2095-3941.2017.0079

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29372109

http://www.w3.org/2001/XMLSchema#string

P932

5785170

http://www.w3.org/2001/XMLSchema#string